Candida is one of the leading causes of
sepsis, and an effective host immune response to Candida critically depends on the
cytokines IL-1β and
IL-18, which need caspase-1 cleavage to become bioactive.
Caspase-12 has been suggested to inhibit caspase-1 activation and has been implicated as a susceptibility factor for bacterial
sepsis. In populations of African descent,
CASPASE-12 is either functional or non-functional. Here, we have assessed the frequencies of both
CASPASE-12 alleles in an African-American Candida
sepsis patients cohort compared to uninfected patients with similar predisposing factors. African-American Candida
sepsis patients (n = 93) and non-infected African-American patients (n = 88) were genotyped for the
CASPASE-12 genotype. Serum
cytokine concentrations of
IL-6,
IL-8, and IFNγ were measured in the serum of infected patients. Statistical comparisons were performed in order to assess the effect of the
CASPASE-12 genotype on susceptibility to
candidemia and on serum
cytokine concentrations. Our findings demonstrate that
CASPASE-12 does not influence the susceptibility to Candida
sepsis, nor has any effect on the serum
cytokine concentrations in Candida
sepsis patients during the course of
infection. Although the functional
CASPASE-12 allele has been suggested to increase susceptibility to bacterial
sepsis, this could not be confirmed in our larger cohort of fungal
sepsis patients.